Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study.
BACKGROUND
Diabetes is known to be associated with cancer of the pancreas, though there is some debate as to whether it is a cause or a consequence of the disease. We investigated the incidence of pancreatic cancer in a cohort of 37926 Israeli women followed for 28-40 years for whom information on diabetes had been collected at the time they gave birth, in 1964-1976, in Jerusalem. There were 54 cases of pancreatic cancer ascertained from the Israel Cancer Registry during follow-up.


METHODS
We used Cox proportional hazards models to adjust for age at baseline and explore effects of other risk factors, including ethnic groups, preeclampsia, birth order and birth weight of offspring.


RESULTS
We observed no cases of pancreatic cancer in the women with insulin dependent diabetes; however, there were five cases in the women with gestational diabetes. The interval between the record of diabetes in pregnancy and the diagnosis of pancreatic cancer ranged from 14-35 years. Women with a history of gestational diabetes showed a relative risk of pancreatic cancer of 7.1 (95% confidence interval, 2.8-18.0).


CONCLUSIONS
We conclude that gestational diabetes is strongly related to the risk of cancer of the pancreas in women in this population, and that gestational diabetes can precede cancer diagnosis by many years.
Perrin
M C
MC
Department of Psychiatry, School of Medicine, New York University, 550 1st Avenue, New York, NY 10017, USA. mcp20@columbia.edu
Terry
M B
MB
Kleinhaus
K
K
Deutsch
L
L
Yanetz
R
R
Tiram
E
E
Calderon
R
R
Friedlander
Y
Y
Paltiel
O
O
Harlap
S
S
D000328:Adult; D016640:Diabetes, Gestational / Q000453:epidemiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007557:Israel / Q000453:epidemiology; D010190:Pancreatic Neoplasms / Q000453:epidemiology* / Q000209:etiology; D011247:Pregnancy; D011446:Prospective Studies; D012307:Risk Factors
Diabetes Care. 2003 Jan;26 Suppl 1:S103-5
12502631
J Clin Invest. 2005 Mar;115(3):485-91
15765129
Cell Biochem Biophys. 2005;43(2):289-330
16049352
Am J Public Health. 2005 Sep;95(9):1536-9
16051928
JAMA. 2006 Apr 5;295(13):1549-55
16595758
Paediatr Perinat Epidemiol. 2007 May;21(3):256-73
17439536
N Engl J Med. 1999 Dec 2;341(23):1749-56
10580075
Gastroenterology. 1999 Dec;117(6):1464-84
10579989
JAMA. 2000 May 17;283(19):2552-8
10815119
Diabetes Care. 2002 Oct;25(10):1862-8
12351492
Cancer. 2004 Jan 1;100(1):149-55
14692035
Mol Cancer. 2003 Jan 6;2:4
12556242
J Clin Endocrinol Metab. 1988 Feb;66(2):266-72
2448329
Cancer Res. 1990 Jan 1;50(1):103-7
2152769
Am J Epidemiol. 1990 Feb;131(2):254-62
2296978
Am J Obstet Gynecol. 1990 Jul;163(1 Pt 1):86-92
2375375
Diabetes. 1991 Dec;40 Suppl 2:25-9
1748260
Am J Epidemiol. 1992 May 1;135(9):965-73
1595695
Diabetes Care. 1993 Jan;16(1):315-7
8422799
JAMA. 1995 May 24-31;273(20):1605-9
7745774
Lancet. 1996 Feb 17;347(8999):444-5
8618487
J Surg Res. 1996 Jun;63(1):310-3
8661216
N Engl J Med. 1997 Feb 27;336(9):633-40
9032050
Diabetes Care. 1998 Aug;21 Suppl 2:B9-13
9704221
Epidemiology. 1998 Nov;9(6):641-7
9799175
JAMA. 2005 Jan 12;293(2):194-202
15644546
Diabetes Care. 2005 Mar;28(3):579-84
15735191
Br J Cancer. 2005 Jun 6;92(11):2076-83
15886696